In the present study, we demonstrated that lactic acid supplementation is sufficient to induce resistance to the Akt inhibitor uprosertib in LS174T and HCT116 colon cancer cell lines and present evidence that metabolic factors may play a role (Fig. 6). The gene discussed is AKT1; the disease is colonic neoplasm.